Pfizer and BioNTech to develop first mRNA-based Shingles vaccine
Product candidates will be based on BioNTech’s proprietary mRNA technology and on Pfizer’s antigen technology. Clinical trials are expected to start in the second half of 2022
Product candidates will be based on BioNTech’s proprietary mRNA technology and on Pfizer’s antigen technology. Clinical trials are expected to start in the second half of 2022
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Given as few as six times per year and demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
The approval is for Cytomegalovirus, a type of Herpes virus
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Taluka level transplant centre will add convenience to patients from rural areas
The Summit will also witness participation of Union Minister of Health & Family Welfare and Chemicals & Fertilizers Dr. Mansukh Mandaviya
Subscribe To Our Newsletter & Stay Updated